Noticias del mercado de valores

Últimas noticias financieras · Actualizado Jul 10, 2026

P S
▬ mixed

Abróchense los cinturones, inversores de fondos indexados S&P 500 y Nasdaq. SpaceX podría convertirse pronto en una de sus mayores posiciones.

Buckle Up, S&P 500 and Nasdaq Index Fund Investors. SpaceX Could Soon Become 1 of Your Largest Positions.

The panel consensus is that a SpaceX IPO at $1.75T with a 4.3% float would likely trigger index-driven demand, but …

Yahoo Finance · May 31, 2026
XMTR
▬ mixed

El CEO de Xometry (XMTR) Recientemente Vendió 50,000 Acciones. ¿Deberías Seguir el Ejemplo?

Xometry's (XMTR) CEO Recently Sold 50K Shares. Should You Follow?

The panelists generally agree that the CEO's indirect sale of shares, while not necessarily a loss of conviction, raises concerns …

Nasdaq · May 31, 2026
FELE
▬ mixed

El Presidente de Franklin Electric (FELE) Vendió 1,900 Acciones. ¿Debería Seguir Su Ejemplo?

Franklin Electric's (FELE) President Sold 1,900 Shares. Should You Follow His Lead?

The panel largely agrees that the insider sale by FELE's groundwater segment president is noise, not a signal, and should …

Nasdaq · May 31, 2026
NVDA
▬ mixed

Las acciones de Nvidia cayeron después de ganancias estelares. ¿Es esto una señal de lo que está por venir para las acciones de Inteligencia Artificial (IA)?

Nvidia Shares Dropped After Stellar Earnings. Is This a Sign of What's Coming for Artificial Intelligence (AI) Stocks?

Despite strong Q1 results, Nvidia's stock faces volatility due to execution risks, competition from hyperscalers and other chipmakers, and geopolitical …

Nasdaq · May 31, 2026
P S
▬ mixed

La inflación se dispara y la Reserva Federal podría hacer algo que no ha hecho desde 2023. Esto es lo que significa para las acciones.

Inflation Is Soaring, and the Federal Reserve Could Do Something It Hasn't Done Since 2023. Here's What It Means for Stocks.

The panel is divided on the market outlook, with concerns about elevated CAPE ratios, potential margin compression due to energy …

Nasdaq · May 31, 2026
DVN
▬ mixed

Mizuho eleva el precio objetivo de Devon Energy (DVN) ante el respaldo de las perspectivas por los mayores precios del petróleo

Mizuho Raises Devon Energy (DVN) Price Target as Higher Oil Prices Support Outlook

Analysts' bullish stance on DVN hinges on persistent high oil prices and refining margins, but panelists raise concerns about the …

Yahoo Finance · May 31, 2026
PTON
▬ mixed

Peleton's (PTON) Chief Commercial Officer Vendió Todas Sus Acciones por $584,000

Peleton's (PTON) Chief Commercial Officer Sold All Their Shares for $584,000

The panel is divided on the significance of Peloton's CCO selling all shares, with some interpreting it as a lack …

Nasdaq · May 31, 2026
OLPX
▼ bear…

¿Está Olaplex Holdings, Inc. (OLPX) entre las Mejores Penny Stocks en Ascenso para Comprar Ahora?

Is Olaplex Holdings, Inc. (OLPX) among the Best Up and Coming Penny Stocks to Buy Now?

The panel consensus is bearish on Olaplex (OLPX), citing concerns about the sustainability of its Q1 revenue beat, the uncertainty …

Yahoo Finance · May 31, 2026
BZAI
▼ bear…

Aquí está el motivo por el que Blaize Holdings, Inc. (BZAI) está entre las mejores acciones penny en alza para comprar ahora

Here is why Blaize Holdings, Inc. (BZAI) is among the Best Up and Coming Penny Stocks to Buy Now

The panel consensus is bearish on Blaize Holdings (BZAI), citing acute concentration risk due to memory bottlenecks and a single …

Yahoo Finance · May 31, 2026
ZVIA
▼ bear…

Zevia PBC (ZVIA): 8 Best Up and Coming Penny Stocks to Buy Now

The panel consensus is overwhelmingly bearish on ZVIA, citing operational execution issues, weak EBITDA, and missed guidance as key concerns. …

Yahoo Finance · May 31, 2026
OKLO NUS
▬ mixed

La energía nuclear es la historia de 2026. Aquí hay 2 acciones para tener durante todo el año.

Nuclear Is the Energy Story of 2026. Here Are 2 Stocks to Own All Year.

The panel consensus is bearish on Oklo and NuScale's near-term prospects due to regulatory, financing, and fuel supply hurdles. While …

Nasdaq · May 31, 2026
JNJ
▬ mixed

J&J Fase 1b/2 OrigAMI-4: Amivantamab Subcutáneo Muestra un ORR del 42% en Cáncer de Cabeza y Cuello

J&J Phase 1b/2 OrigAMI-4: Subcutaneous Amivantamab Shows 42% ORR In Head & Neck Cancer

Johnson & Johnson's amivantamab showed promising results with a 42% ORR in heavily pretreated head and neck cancer, but further …

Nasdaq · May 31, 2026